PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Teva debuts generics of Delzicol and Tarceva in the USA
2 Undervalued Stocks Among Berkshire's Latest Buys | Morningstar
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Teva Pharmaceuticals USA - ZIP 45213, NAICS 523930
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Drugmakers Delving Into Multiple Sclerosis Market | Morningstar
Teva: Generic drug giant stumbles into NJ with $40M tax break from you
Morningstar Advisor - June/July 2012 - 46
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
PPT - TECH or TEVA PowerPoint Presentation, free download - ID:1603766
Morningstar Advisor - April/May 2010 - 63
The Hemophilia Market - Morningstar
Morningstar Advisor - June/July 2012 - 46
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Lax Opioid Settlements Helped Boost This Drugmaker's Stock
Argus Downgrades Teva Pharmaceutical Industries to Hold From Buy | MarketScreener
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Shield Therapeutics PLC to continue “robust” defence of IP as Teva Pharmaceutical Industries Ltd appeals Feraccru ruling
Teva, Sun Pharma to pay $2.15 billion to settle Pfizer patent suit | Reuters
TEVA Institutional Ownership - Teva Pharmaceutical Industries Ltd. Stock
Morningstar Investment Services LLC ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
3 Undervalued Warren Buffett Stocks | Morningstar
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
